Analystreport

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) had its price target lowered by analysts at Alliance Global Partners from $14.00 to $8.00.

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report